Search Results - "Kloke, O."

Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma by Kivelä, T, Suciu, S, Hansson, J, Kruit, W.H.J, Vuoristo, M.-S, Kloke, O, Gore, M, Hahka-Kemppinen, M, Parvinen, L.-M, Kumpulainen, E, Humblet, Y, Pyrhönen, S

“…This EORTC multicentre study analysed the efficacy and tolerability in patients with metastatic uveal melanoma of BOLD chemotherapy in combination with…”
Get full text

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of multiple myeloma by Harrouseau, J.-L., Greil, R., Kloke, O.

Get full text

Toxicity and/or insufficient analgesia by opioid therapy : risk factors and the impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center by KLOKE, M, RAPP, M, BOSSE, B, KLOKE, O

“…The charts of 273 cancer patients were retrospectively analyzed in order (1) to evaluate the frequency of opioid change (OCH) when adjuvants…”
Get full text

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of osteosarcoma by Saeter, G., Kloke, O., Jelic, S.

Get full text

ESMO Minimum Clinical Recommendations for the diagnosis, treatment and follow-up of chronic myelogenous leukemia (CML) by Simonsson, B., Kloke, O., Stahel, R.A.

Get full text

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of newly diagnosed large cell non-Hodgkin's lymphoma by Jost, L.M., Kloke, O., Stahel, R.A.

Get full text

Interferon alfa as primary treatment of chronic myeloid leukemia : long-term follow-up of 71 patients observed in a single center by KLOKE, O, OPALKA, B, NIEDERLE, N

“…The purpose of this study was to evaluate the long-term outcome of interferon (IFN) alfa treatment in patients with Philadelphia chromosome-positive chronic…”
Get full text

Combination therapy for chronic myelogenous leukemia with interferon alfa and other cytokines by Kloke, O

Get more information

ESMO Minimum Clinical Recommendations - the beginning of a process by Stahel, R., Purkalne, G., Herrstedt, J., Jelic, S., Fevers, B., Kloke, O., Mellstedt, H., Pavlidis, H., Jost, L.

Get full text

Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy : results of a randomized trial by KLOKE, O, KLAASSEN, U, DONSBACH, G.-M, BECHTEL, C, RUDOLPH, R, BERKE, A, BORQUEZ, D, HAWIG, I, HIRCHE, H, SCHINDLER, A. E, SEEBER, S, BECHER, R, OBERHOFF, C, HARTWICH, G, SZANTO, J, WOLF, E, HECKMANN, M, HUHN, R, STEPHAN, L, SCHNEPPER, U

“…The purpose of this randomized phase III trial was to study whether medroxyprogesterone acetate (MPA) maintenance treatment prolongs the time to progression in…”
Get full text

Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia by Kloke, O, Niederle, N, Qiu, J Y, Wandl, U, Moritz, T, Nagel-Hiemke, M, Hawig, I, Opalka, B, Seeber, S, Becher, R

“…The objective of this study was to investigate the prognostic impact of the reduction of Philadelphia chromosome (Ph) positive metaphases by treatment of…”
Get more information

Liver failure due to recombinant alpha interferon for chronic myelogenous leukaemia by Wandl, U B, Kloke, O, Niederle, N

Get more information

Prognostic impact of interferon alpha-induced cytogenetic remission in chronic myelogenous leukaemia: long-term follow-up by Kloke, O, Niederle, N, Opalka, B, Hawig, I, Seeber, S, Becher, R

“…To evaluate the long-term impact of the reduction of Philadelphia chromosome (Ph)-positive metaphases by treatment of chronic myelogenous leukaemia (CML) with…”
Get more information

No correlation between the type of bcr-abl hybrid messenger RNA and platelet counts in chronic myelogenous leukemia by Opalka, B, Wandl, U B, Stutenkemper, R, Kloke, O, Seeber, S, Niederle, N

Get full text

The impact of interferon versus busulfan therapy on the reticulin stain-measured fibrosis in CML--a comparative morphometric study on sequential trephine biopsies by Thiele, J, Kvasnicka, H M, Niederle, N, Zirbes, T K, Schmidt, M, Dammasch, J, Meuter, B R, Leder, L D, Kloke, O, Diehl, V

“…To evaluate treatment-related changes of the reticulin stain-measured fibrosis in Ph(1+)-CML, a clinicopathological study was performed on sequential trephine…”
Get full text

Epirubicin and ifosfamide in metastatic breast cancer by Becher, R, Kloke, O, Hayungs, J, Hartwich, G, Bartels, H, Szanto, J, Wolf, E, Illiger, H J, Halabi, S, Rieche, K, Hering, K G, Ohl, S, DeDycker, R, Huhn, R, Fischedick, A R, Höfeler, H, Pielken, H J, Hawig, I, Hirche, H, Seeber, S

“…In a randomized, phase II trial, we evaluated the effectiveness of continued chemotherapy with epirubicin/ ifosfamide versus unmaintained treatment…”
Get more information

Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alpha by Doberauer, C, Mengelkoch, B, Kloke, O, Wandl, U, Niederle, N

“…Fourteen patients with metastatic carcinoid tumors were treated with recombinant interferon alpha-2b at a dosage of 3-4 x 10(6) IU s.c. daily or every second…”
Get more information

No correlation between site of breakpoint in the BCR gene and platelet counts in Philadelphia chromosome-positive CML by Opalka, B, Wandl, U B, Kloke, O, Beer, U, Seeber, S, Niederle, N

“…In chronic myelogenous leukemia (CML) malignant cells are characterised by the Philadelphia chromosome (Ph), resulting from a translocation t(9;22). The…”
Get more information

Interaction of cyclosporin A with antineoplastic agents by Kloke, O, Osieka, R

“…A synergistic effect of etoposide and cyclosporin A was observed in a patient with acute T-lymphocytic leukemia in relapse. The concomitant administration of…”
Get full text

Chemotherapy of non-small-cell bronchial carcinoma in elderly patients by Kloke, O

“…The incidence of lung cancer increases with age, and non-small-cell histotypes account for approximately 85% of lung cancers in patients aged older than 65…”
Get full text